CollPlant Receives $6M Investment To Develop Cosmetics

December 4, 2013 | Israeli biomed company CollPlant, which develops various collagen products for the pharmaceutical industry, has announced the signing of a memorandum of understanding with an unnamed US-based company. According to the agreement, CollPlant will receive a total of $6 million for selling the rights to use their collagen production technology for the cosmetics industry.